Quinidine vs Dabigatran Etexilate

Interacting Drugs
Quinidine
vs
Dabigatran Etexilate
Security Level
Moderate, Consider therapy modification
Mechanism
Dabigatran Etexilate: P-glycoprotein/ABCB1 Inhibitors may increase serum concentrations of the active metabolite(s) of Dabigatran Etexilate.
Management
Dabigatran dose reductions may be needed. According to Canadian labeling, dabigatran dose for prevention of venous thromboembolism post hip or knee replacement should be reduced to 150 mg/day in patients receiving amiodarone, verapamil, or quinidine.

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Quinidine vs Dabigatran Etexilate


Other Interactions of Quinidine

We are Developing Our database, More results coming soon.

Other Interactions of Dabigatran Etexilate

We are Developing Our database, More results coming soon.

Quinidine vs Dabigatran Etexilate

Interacting Drugs
Quinidine
vs
Dabigatran Etexilate
Security Level
Moderate, Consider therapy modification
Mechanism
Dabigatran Etexilate: QuiNIDine may increase the serum concentration of Dabigatran Etexilate.
Management
Canadian (but not U.S.) prescribing information recommends dosing dabigatran 2 hours prior to quinidine, and limiting dabigatran VTE prevention dose post hip/knee replacement to 150 mg/day in patients receiving quinidine.

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Quinidine vs Dabigatran Etexilate


Other Interactions of Quinidine

We are Developing Our database, More results coming soon.

Other Interactions of Dabigatran Etexilate

We are Developing Our database, More results coming soon.